Article metrics

Original research
Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial

 

Online download statistics by month:

Online download statistics by month: March 2021 to May 2022

AbstractFullPdf
Mar 2021383384139
Apr 2021260260131
May 202139739758
Jun 2021159159102
Jul 202112112166
Aug 202114214242
Sep 2021939352
Oct 2021878757
Nov 2021999855
Dec 2021909035
Jan 2022889351
Feb 2022656745
Mar 2022555530
Apr 202210210556
May 20229910065
Total22402251984